1. Home
  2. SCI vs ABVX Comparison

SCI vs ABVX Comparison

Compare SCI & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Service Corporation International

SCI

Service Corporation International

HOLD

Current Price

$76.74

Market Cap

11.3B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$130.42

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCI
ABVX
Founded
1962
2013
Country
United States
France
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
9.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCI
ABVX
Price
$76.74
$130.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$92.00
$112.83
AVG Volume (30 Days)
832.8K
1.5M
Earning Date
10-29-2025
08-11-2025
Dividend Yield
1.66%
N/A
EPS Growth
8.17
N/A
EPS
3.71
N/A
Revenue
$4,290,729,999.00
$7,073,400.00
Revenue This Year
$4.08
$6.80
Revenue Next Year
$3.47
N/A
P/E Ratio
$20.80
N/A
Revenue Growth
3.41
N/A
52 Week Low
$71.75
$4.77
52 Week High
$86.83
$130.25

Technical Indicators

Market Signals
Indicator
SCI
ABVX
Relative Strength Index (RSI) 40.35 68.06
Support Level $75.34 $107.06
Resistance Level $78.81 $130.25
Average True Range (ATR) 1.51 7.01
MACD -0.11 -0.23
Stochastic Oscillator 28.90 74.57

Price Performance

Historical Comparison
SCI
ABVX

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: